Sleep aids market size, share, analysis & forecast by 2023.

Shopping Cart is Empty..

$ 0

Apr 2017 | 579 Views

Sleep Aids Market by Product (Mattress & Pillows, Sleep Laboratories, Medications, and Sleep Apnea Devices) and Sleep Disorder (Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking, and Other Sleep Disorders) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Healthcare	LI 171533	Pages: 120	Formats*:
Apr 2017 \| 579 Views	Charts: 58	Tables: 55	Author(s): Onkar Sumant and Tenzin Kunsel

Sleep Aids Market Overview:

Global Sleep Aids Market was valued at $49,543 million in 2016, and is estimated to reach $79,851 million by 2022, registering a CAGR of 7.0% from 2017 to 2023. Sleep is a biological requirement that maintain metabolic homeostasis, influences memory and other cognitive function, and regulates immune function. Sleep aids are drugs and medical devices used to diagnose and treat various sleep disorders, such as sleep apnea and insomnia. Lack of quality sleep leads to sleep disorders, which are caused due to medical issues, physical disturbances, environmental problems, and psychiatric disorders. These sleep disorders are expected to adversely affect the human health and lead to number of chronic diseases, such as high blood pressure, diabetes, arthritis, and stroke. Thus, it is important to treat and diagnose these disorders at an early stage.

Global Sleep Aids Market Segmentation

The global sleep aids market is segmented based on product, sleep disorder, and geography. Based on product, it is classified into mattress & pillows, sleep laboratories, medications, and sleep apnea devices. The medication segment is further divided into prescription-based drugs, over-the-counter (OTC) drugs, and herbal drugs. Based on sleep disorder, it is categorized into insomnia, sleep apnea, restless leg syndrome, narcolepsy, sleep walking, and other sleep disorders. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Drivers, Restrains, and Opportunities

The impact of the driving factors is expected to surpass the effect of restraints. Moreover, the increase in awareness about sleep disorders and technological advancements are expected to provide new market opportunities to sleep aids manufacturers in the near future.

Drivers, Restrains, and Opportunities

Global Sleep Aids Market Key Geographical Segment

North America accounted for the highest market share in the sleep aids market in 2016, and is expected to maintain its dominance throughout the forecast period.

Global Sleep Aids Market, By Geography, 2016 (%)

The key players operating in the global sleep aids market include Koninklijke Philips N.V., Merck & Co., Sanofi, DeVilbiss Healthcare LLC., Pfizer Inc., SleepMed Inc., Cadwell Laboratories Inc., Compumedics Limited, Natus Medical Incorporated, and GlaxoSmithKline plc.

The other significant players in the value chain include Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, CareFusion Corporation, Tempur-Pedic Management Inc., Serta International, and Drive Medical Ltd.

Key Benefits for Stakeholders

This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
Market estimations are based on the comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to product, sleep disorder, and geography.
In-depth analysis based on geography assists to understand the regional market and strategic business planning.
The developmental strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Sleep Aids Market Key Segments:

By Product

Mattresses & Pillows
Sleep Laboratories
Medications
- Prescription-based Drugs
- OTC drugs
- Herbal drugs
Sleep Apnea Devices

By Sleep Disorder

Insomnia
Sleep Apnea
Restless Legs Syndrome
Narcolepsy
Sleep Walking
Other Sleep Disorders

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Republic of South Africa
- Saudi Arabia
- Rest of LAMEA

License Type

Data Pack

Single User PDF

Five User Online/PDF

Enterprise Online/PDF

LICENSE INFO

Users/Sharing

Restricted to one authorized user

Limited to 5 authorized users

Unlimited within company / enterprise

Printing

One Print only

Up to Five Copies

Unlimited within company / enterprise

Delivery Formats

ADDED BENIFITS

20% Free customization (Pre-sale)

16 Analyst hour support (Post Sale)

40 Analyst hour support (Post Sale)

160 hours of mini-consult

Free quarterly industry update

Free report on update (within 180 days)

MULTIPLE PURCHASE

Complimentary report with 2 reports

Complimentary report with 3 reports

Subscription Model

Have questions ?

Need to add more ?

* Taxes/Fees, If applicable, will be
added at the checkout

Need More Information

+1-503-894-6022

help@alliedmarketresearch.com

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to eliminate redundant information to provide valued information and save time of the reader

Get fresh content delivered

Get insights on topics that matter to your business. Stay updated on the areas that interest you.

Report Title: Sleep Aids Market by Product (Mattress & Pillows, Sleep Laboratories, Medications, and Sleep Apnea Devices) and Sleep Disorder (Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking, and Other Sleep Disorders) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Select Chapters

Chapter 1 Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7

Full Name: *:

Company Name: *:

Job Role: *:

Email: *:

Country: *:

Contact Number: *:

How can we help? *:

Security Code: *:

STAY WITH US

WE ACCEPT

* Pricing on the website is provided for single users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at +1-800-792-5285 or send an email to sales@alliedmarketresearch.com
Title/ Chapter Name	Chapter Price

Chapter: 1 INTRODUCTION 1.1. REPORT DESCRIPTION 1.2. KEY BENEFITS 1.3. KEY MARKET SEGMENTS 1.4. RESEARCH METHODOLOGY 1.4.1. Secondary research 1.4.2. Primary research 1.4.3. Analyst tools and models	$0(SU)
Chapter: 2 EXECUTIVE SUMMARY 2.1. CXO PERSPECTIVE
Chapter: 3 MARKET OVERVIEW 3.1. MARKET DEFINITION AND SCOPE 3.2. KEY BENEFITS 3.2.1. Top investment pockets 3.2.2. Top winning strategies 3.3. PATENT ANALYSIS 3.3.1. Patent analysis by year 3.3.2. Patent analysis by region 3.3.3. Patent analysis by sleep disorder 3.4. GOVERNMENT REGULATIONS 3.4.1. U.S. FDA 3.4.2. Europe CE Mark 3.4.3. Ministry of Health, Labor, and Welfare (MHLW) 3.5. TOP PLAYERS POSITIONING, 2016 3.6. MARKET DYNAMICS 3.6.1. Drivers 3.6.1.1. Modern lifestyle increases the risk of sleep disorders 3.6.1.2. Stressful Work Condition and Working in Shifts 3.6.1.3. Rise in geriatric and obese population 3.6.2. Restraints 3.6.2.1. Adverse effects of sleep aid medication 3.6.2.2. Patent expiration 3.6.3. Opportunities 3.6.3.1. Technological Advancements Leading to Better Adoption 3.6.3.2. Untapped Markets in Developing Economies
Chapter: 4 GLOBAL SLEEP AIDS MARKET, BY PRODUCT TYPE 4.1. OVERVIEW 4.1.1. Market size and forecast 4.2. MATTRESSES AND PILLOWS 4.2.1. Key market trends 4.2.2. Key growth factors and opportunities 4.2.3. Market size and forecast 4.3. SLEEP LABORATORIES 4.3.1. Key market trends 4.3.2. Key growth factors and opportunities 4.3.3. Market size and forecast 4.4. MEDICATIONS 4.4.1. Key market trends 4.4.2. Key growth factors and opportunities 4.4.3. Market size and forecast 4.4.4. Prescription-based drugs 4.4.5. OTC drugs 4.5. SLEEP APNEA DEVICES 4.5.1. Key market trends 4.5.2. Key growth factors and opportunities 4.5.3. Market size and forecast
Chapter: 5 SLEEP AIDS MARKET, BY SLEEP DISORDER 5.1. OVERVIEW 5.1.1. Market size and forecast 5.2. INSOMNIA 5.2.1. Market size and forecast 5.3. SLEEP APNEA 5.3.1. Market size and forecast 5.4. RESTLESS LEGS SYNDROME 5.4.1. Market size and forecast 5.5. NARCOLEPSY 5.5.1. Market size and forecast 5.6. SLEEPWALKING 5.6.1. Market size and forecast 5.7. OTHERS 5.7.1. Market size and forecast
Chapter: 6 SLEEP AIDS MARKET, BY GEOGRAPHY 6.1. OVERVIEW 6.1.1. Market size and forecast 6.2. NORTH AMERICA 6.2.1. Key market trends 6.2.2. Key growth factors and opportunities 6.2.3. Market size and forecast 6.2.3.1. U.S. market size and forecast 6.2.3.2. Canada market size and forecast 6.2.3.3. Mexico market size and forecast 6.3. EUROPE 6.3.1. Key market trends 6.3.2. Key growth factors and opportunities 6.3.3. Market size and forecast 6.3.3.1. Germany market size and forecast 6.3.3.2. France market size and forecast 6.3.3.3. UK market size and forecast 6.3.3.4. Italy market size and forecast 6.3.3.5. Rest of Europe market size and forecast 6.4. ASIA-PACIFIC 6.4.1. Key market trends 6.4.2. Key growth factors and opportunities 6.4.3. Market size and forecast 6.4.3.1. Japan market size and forecast 6.4.3.2. China market size and forecast 6.4.3.3. Australia market size and forecast 6.4.3.4. India market size and forecast 6.4.3.5. Rest of Asia-Pacific market size and forecast 6.5. LAMEA 6.5.1. Key market trends 6.5.2. Key growth factors and opportunities 6.5.3. Market size and forecast 6.5.3.1. Brazil market size and forecast 6.5.3.2. Turkey market size and forecast 6.5.3.3. Saudi Arabia market size and forecast 6.5.3.4. South Africa market size and forecast 6.5.3.5. Rest of LAMEA market size and forecast
Chapter: 7 COMPANY PROFILES 7.1. CADWELL INDUSTRIES INC. 7.1.1. Company overview 7.1.2. Company snapshot 7.1.3. Operating business segments 7.1.4. Product portfolio 7.1.5. Business performance 7.1.6. Key strategic moves and developments 7.2. COMPUMEDICS LIMITED 7.2.1. Company overview 7.2.2. Company snapshot 7.2.3. Operating business segments 7.2.4. Product portfolio 7.2.5. Business performance 7.2.6. Key strategic moves and developments 7.3. DRIVE DEVILBISS HEALTHCARE 7.3.1. Company overview 7.3.2. Company snapshot 7.3.3. Operating business segments 7.3.4. Product portfolio 7.3.5. Business performance 7.3.6. Key strategic moves and developments 7.4. GLAXOSMITHKLINE PLC 7.4.1. Company overview 7.4.2. Company snapshot 7.4.3. Operating business segments 7.4.4. Product portfolio 7.4.5. Business performance 7.4.6. Key strategic moves and developments 7.5. MERCK & CO., INC. 7.5.1. Company overview 7.5.2. Company snapshot 7.5.3. Operating business segments 7.5.4. Product portfolio 7.5.5. Business performance 7.5.6. Key strategic moves and developments 7.6. NATUS MEDICAL INCORPORATED 7.6.1. Company overview 7.6.2. Company snapshot 7.6.3. Operating business segments 7.5.4. Product portfolio 7.5.5. Business performance 7.6.6. Key strategic moves and developments 7.7. PFIZER INC. 7.7.1. Company overview 7.7.2. Company snapshot 7.7.3. Operating business segments 7.7.4. Product portfolio 7.7.5. Business performance 7.7.6. Key strategic moves and developments 7.8. KONINKLIJKE PHILIPS N.V. 7.8.1. Company overview 7.8.2. Company snapshot 7.8.3. Operating business segments 7.8.4. Product portfolio 7.8.5. Business performance 7.8.6. Key strategic moves and developments 7.9. SANOFI 7.9.1. Company overview 7.9.2. Company snapshot 7.9.3. Product portfolio 7.9.4. Business performance 7.9.5. Key strategic moves and developments 7.10. SLEEPMED INC. 7.10.1. Company overview 7.10.2. Company snapshot 7.10.3. Operating business segments 7.10.4. Product portfolio 7.10.5. Business performance 7.10.6. Key strategic moves and developments LIST OF TABLES TABLE 1. GLOBAL SLEEP AIDS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION) TABLE 2. SLEEP AIDS MATTRESS AND PILLOWS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 3. SLEEP AIDS SLEEP LABORATORIES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 4. SLEEP AIDS MEDICATIONS MARKET, BY TYPE, 2016-2023 ($MILLION) TABLE 5. SLEEP AIDS PRESCRIPTION-BASED DRUGS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 6. SLEEP AIDS OTC DRUGS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 7. GLOBAL SLEEP AIDS MARKET, BY SLEEP DISORDER, 2016-2023 ($MILLION) TABLE 8. INSOMNIA SLEEP AIDS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 9. SLEEP APNEA SLEEP AIDS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 10. RESTLESS LEGS SYNDROME SLEEP AIDS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 11. NARCOLEPSY SLEEP AIDS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 12. SLEEPWALKING MEDICAL SLEEP AIDS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 13. OTHER SLEEP DISORDERS SLEEP AIDS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION) TABLE 14. NORTH AMERICA SLEEP AIDS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION) TABLE 15. NORTH AMERICA SLEEP AIDS MARKET, BY MEDICATION, 2016-2023 ($MILLION) TABLE 16. NORTH AMERICA SLEEP AIDS MARKET, BY SLEEP DISORDER, 2016-2023 ($MILLION) TABLE 17. NORTH AMERICA SLEEP AIDS MARKET, BY COUNTRY, 2016-2023 ($MILLION) TABLE 18. EUROPE SLEEP AIDS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION) TABLE 19. EUROPE SLEEP AIDS MARKET, BY MEDICATION, 2016-2023 ($MILLION) TABLE 20. EUROPE SLEEP AIDS MARKET, BY SLEEP DISORDER, 2016-2023 ($MILLION) TABLE 21. EUROPE SLEEP AIDS MARKET, BY COUNTRY, 2016-2023 ($MILLION) TABLE 22. ASIA-PACIFIC SLEEP AIDS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION) TABLE 23. ASIA-PACIFIC SLEEP AIDS MARKET, BY MEDICATION, 2016-2023 ($MILLION) TABLE 24. ASIA-PACIFIC SLEEP AIDS MARKET, BY SLEEP DISORDER, 2016-2023 ($MILLION) TABLE 25. ASIA-PACIFIC SLEEP AIDS MARKET, BY COUNTRY, 2016-2023 ($MILLION) TABLE 26. LAMEA SLEEP AIDS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION) TABLE 27. LAMEA SLEEP AIDS MARKET, BY MEDICATION, 2016-2023 ($MILLION) TABLE 28. LAMEA SLEEP AIDS MARKET, BY SLEEP DISORDER, 2016-2023 ($MILLION) TABLE 29. LAMEA SLEEP AIDS MARKET, BY COUNTRY, 2016-2023 ($MILLION) TABLE 30. CADWELL: COMPANY SNAPSHOT TABLE 31. CADWELL: OPERATING SEGMENTS TABLE 32. CADWELL: PRODUCT PORTFOLIO TABLE 33. COMPUMEDICS: COMPANY SNAPSHOT TABLE 34. COMPUMEDICS: OPERATING SEGMENTS TABLE 35. DRIVE DEVILBISS HEALTHCARE: COMPANY SNAPSHOT TABLE 36. DRIVE DEVILBISS HEALTHCARE: OPERATING SEGMENTS TABLE 37. DRIVE DEVILBISS HEALTHCARE: PRODUCT PORTFOLIO TABLE 38. GSK: COMPANY SNAPSHOT TABLE 39. GSK: OPERATING SEGMENTS TABLE 40. MERCK: COMPANY SNAPSHOT TABLE 41. MERCK: OPERATING SEGMENTS TABLE 42. NATUS: PRODUCT PORTFOLIO TABLE 43. NATUS: COMPANY SNAPSHOT TABLE 44. NATUS: OPERATING SEGMENTS TABLE 45. PFIZER: COMPANY SNAPSHOT TABLE 46. PFIZER: OPERATING SEGMENTS TABLE 47. PFIZER: PRODUCT PORTFOLIO TABLE 48. PHILIPS: COMPANY SNAPSHOT TABLE 49. PHILIPS: OPERATING SEGMENTS TABLE 50. PHILIPS: PRODUCT PORTFOLIO TABLE 51. SANOFI: COMPANY SNAPSHOT TABLE 52. SANOFI: PRODUCT PORTFOLIO TABLE 53. SLEEPMED: COMPANY SNAPSHOT TABLE 54. SLEEPMED: OPERATING SEGMENTS TABLE 55. SLEEPMED: PRODUCT PORTFOLIO LIST OF FIGURES FIGURE 1. MARKET SEGMENTATION FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL SLEEP AIDS MARKET FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2017) (%) FIGURE 4. TOP WINNING STRATEGIES IN SLEEP AIDS MARKET (2015-2017) FIGURE 5. TOP WINNING STRATEGIES: TYPE AND NATURE FIGURE 11. TOP PLAYER POSITIONING: GLOBAL SLEEP AIDS MARKET, 2016 FIGURE 12. GLOBAL SLEEP AIDS MARKET: RESTRAINTS AND DRIVERS FIGURE 13. GLOBAL SLEEP AIDS MARKET SEGMENTATION, BY APPLICATION FIGURE 14. U.S. SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 15. CANADA SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 16. MEXICO SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 17. GERMANY SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 18. FRANCE SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 19. UK SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 20. ITALY SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 21. REST OF EUROPE SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 22. JAPAN SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 23. CHINA SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 24. AUSTRALIA SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 25. INDIA SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 26. REST OF ASIA-PACIFIC SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 27. BRAZIL SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 28. TURKEY SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 29. SAUDI ARABIA SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 30. SOUTH AFRICA SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 31. REST OF LAMEA SLEEP AIDS MARKET, 2016-2023 ($MILLION) FIGURE 32. CADWELL: REVENUE, 2016-2016 ($MILLION) FIGURE 33. CADWELL: REVENUE SHARE BY GEOGRAPHY, 2016 (%) FIGURE 34. COMPUMEDICS: REVENUE, 2016-2016 ($MILLION) FIGURE 35. COMPUMEDICS: REVENUE BY SEGMENT, 2016 (%) FIGURE 36. DRIVE DEVILBISS HEALTHCARE: REVENUE, 2016-2016 ($MILLION) FIGURE 37. DRIVE DEVILBISS HEALTHCARE: REVENUE SHARE BY PRODUCT TYPE, 2016 (%) FIGURE 38. DRIVE DEVILBISS HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2016 (%) FIGURE 39. GSK: REVENUE, 2016-2016 ($MILLION) FIGURE 40. GSK: REVENUE SHARE BY SEGMENT, 2016 (%) FIGURE 41. GSK: REVENUE SHARE BY GEOGRAPHY, 2016 (%) FIGURE 42. MERCK: REVENUE, 2016-2016 ($MILLION) FIGURE 43. MERCK: REVENUE BY SEGMENT, 2016 (%) FIGURE 44. MERCK: REVENUE BY GEOGRAPHY, 2016 (%) FIGURE 45. NATUS: REVENUE, 2016-2016 ($MILLION) FIGURE 46. NATUS: REVENUE SHARE BY GEOGRAPHY, 2015 (%) FIGURE 47. PFIZER: REVENUE, 2016-2016 ($MILLION) FIGURE 48. PFIZER: REVENUE SHARE BY SEGMENT, 2016 (%) FIGURE 49. PFIZER: REVENUE SHARE BY GEOGRAPHY, 2016 (%) FIGURE 50. PHILIPS: REVENUE, 2016-2016 ($MILLION) FIGURE 51. PHILIPS: REVENUE SHARE BY SEGMENT, 2016 (%) FIGURE 52. PHILIPS: REVENUE SHARE BY GEOGRAPHY, 2016 (%) FIGURE 53. SANOFI: REVENUE, 2016-2016 ($MILLION) FIGURE 54. SANOFI: REVENUE SHARE BY SEGMENT, 2016 (%) FIGURE 55. SANOFI: REVENUE SHARE BY GEOGRAPHY, 2016 (%) FIGURE 56. SLEEPMED: REVENUE, 2016-2016 ($MILLION) FIGURE 57. SLEEPMED: REVENUE SHARE BY SEGMENT, 2016 (%) FIGURE 58. SLEEPMED: REVENUE SHARE BY GEOGRAPHY, 2016 (%)